Clinical Trial Update: A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

This document describes a Phase 4 clinical trial evaluating adalimumab for severe plaque psoriasis in Chinese children, which has not yet started recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Severe Plaque Psoriasis in Chinese Children | Phase 4 | Status: NOT_YET_RECRUITING